Health Care [ 7/12 ] | Health Care Equipment & Supplies [ 42/73 ]
NASDAQ | Common Stock
EDAP TMSS. A., together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally.
The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments.
The HIFU segment develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications.
This segment also offers Focal One, a HIFU robotic system to treat patients diagnosed with prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services.
The ESWL segment manufactures and markets lithotripter for the treatment of urinary tract stones; and provides disposables, replacement parts, and services for lithotripters.
This segment also sells spare parts and disposables, such as electrodes.
The Distribution segment markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services.
It markets and sells its products through its direct marketing and sales channels, as well as through third-party distributors and agents.
The company serves academic, public, and private hospitals as well as urology clinics.
EDAP TMSS. A. was incorporated in 1979 and is based in Vaulx-en-Velin, France.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 28, 25 | -0.17 Increased by +3.28% | -0.16 Decreased by -8.68% |
| May 15, 25 | -0.19 Decreased by -58.33% | -0.15 Decreased by -25.08% |
| Mar 27, 25 | -0.05 Increased by +64.29% | -0.10 Increased by +50.00% |
| Nov 7, 24 | -0.18 Decreased by -63.64% | -0.16 Decreased by -12.50% |
| Aug 22, 24 | -0.18 Decreased by -38.46% | -0.13 Decreased by -38.46% |
| May 16, 24 | -0.12 Increased by +40.00% | -0.11 Decreased by -9.09% |
| Mar 27, 24 | -0.14 Increased by 0.00% | -0.04 Decreased by -250.00% |
| Nov 9, 23 | -0.11 Decreased by -27.60 K% | -0.11 |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 25 | 13.56 M Decreased by -9.59% | -7.07 M Decreased by -54.70% | Decreased by -52.18% Decreased by -71.10% |
| Dec 31, 24 | 20.32 M Increased by +6.32% | -1.94 M Increased by +60.50% | Decreased by -9.55% Increased by +62.85% |
| Sep 30, 24 | 13.10 M Increased by +11.60% | -6.40 M Decreased by -62.16% | Decreased by -48.85% Decreased by -45.30% |
| Jun 30, 24 | 15.79 M Increased by +10.59% | -6.13 M Decreased by -30.52% | Decreased by -38.83% Decreased by -18.03% |
| Mar 31, 24 | 15.00 M Decreased by -4.60% | -4.57 M Increased by +10.88% | Decreased by -30.49% Increased by +6.59% |
| Dec 31, 23 | 19.11 M Increased by +29.16% | -4.91 M Increased by +34.41% | Decreased by -25.71% Increased by +49.22% |
| Sep 30, 23 | 11.74 M Decreased by -4.13% | -3.95 M Decreased by -30.45 K% | Decreased by -33.62% Decreased by -31.76 K% |
| Jun 30, 23 | 14.28 M Increased by +0.91% | -4.70 M Decreased by -357.14% | Decreased by -32.90% Decreased by -354.82% |